-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
January 01, 2009 - In
Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the
new … limited
numbers of human subjects to gather preliminary evidence regarding effectiveness and additional
safety … Phase III refers to controlled clinical studies intended to provide a reasonable
assurance of safety … studies
performed once a technology has gained marketing approval; these studies address long-term
safety … Trials in volunteers usually go before trials in patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
January 01, 2009 - In
Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the
new … limited
numbers of human subjects to gather preliminary evidence regarding effectiveness and additional
safety … Phase III refers to controlled clinical studies intended to provide a reasonable
assurance of safety … studies
performed once a technology has gained marketing approval; these studies address long-term
safety … Trials in volunteers usually go before trials in patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
December 01, 2017 - information, i.e., in the context of available resources
and circumstances presented by individual patients … safety and quality of care. … 15 percent of the content of these protocols is routinely
adapted to meet the needs of individual patients … outcome data) and external (published research) evidence for
patients and clinicians.66
Our work … and value of
patient care.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
April 09, 2020 - U.S. were estimated for 2019.2 Surgery is a component of the standard
treatment strategy for most patients … satisfaction and fewer
complications in patients undergoing postmastectomy radiation therapy.26 But … FDA Update on the
Safety of Silicone Gel-Filled Breast Implants. 2011. https://www.fda.gov/media/80685 … : FDA
Safety Communication.; 2019. https://www.fda.gov/medical-devices/safety-communications/fda-
requests-allergan-voluntarily-recall-natrelle-biocell-textured-breast-implants-and-tissue … your-rights-after-a-mastectomy.pdf
https://www.fda.gov/media/80685/download
https://www.fda.gov/medical-devices/safety-communications
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - selection: The domain patient selection addresses whether the selection of
patients could have introduced … Patient-centered outcomes are considered
direct. … Long-Term Effects of Stimulant Treatment for
ADHD: What Can We Tell Our Patients? … Safety of Vaccines Used for Routine
Immunization in the United States: An Update. … Safety of probiotics used to reduce risk and
prevent or treat disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
September 07, 2012 - The safety signal
uncovered by the FDA was an excess of fetal death in patients
exposed to 17P. … , of note each of these is mediated
by the care provider as part of the process of
care; none are patient … A it must work for
patient B" clearly does not apply for 17OH. … Given that this document could be
used to provide guidelines for patient care and change
reimbursement … Physicians need to inform patients that there is a potential safety
signal with the administration of
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Although propofol may be preferred for these
reasons, its use is complicated by safety concerns. … of the controversy among
clinical specialties (gastroenterology versus anesthesiology) about its safety … Patient
acceptance of the technology might be low, although one expert thought that elderly patients … Clinicians can access objective, accurate,
and timely data about patient adherence, to monitor patients … It may be
solely age-based (i.e., patients 65 years and older) or also based on patient complaint and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - The second-generation
sulfonylureas, which are used today, were
Comparative Effectiveness and Safety … Do oral diabetes medications for the treatment of
adults with type 2 diabetes differ in their safety … similar between metformin and
other oral diabetes medications or placebo (8.4 vs. 9
cases per 100,000 patient-years … additional
limitations that influenced their conclusions was their
decision to include studies with diverse patient … similar between metformin and other
oral diabetes medications or placebo (8.4 vs. 9 cases per 100,000
patient-years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - The pharmacokinetics, efficacy, and safety
of a novel selective-dose cannabis inhaler in
patients with … Efficacy, tolerability
and safety of cannabinoids for management
of pain in adult patients with multiple … Off-
label use of cannabinoids efficacy and
safety. … Safety and Efficacy of Medical
Cannabis in Fibromyalgia. … Care of the Patient
Using Cannabis.
-
effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
October 01, 2007 - EDITORIAL
The Comparative Effectiveness and Safety Emerging
Methods Symposium
A Tribute to Harry A. … knowledge
about the development and application of methods pertaining to comparative effectiveness
and safety … core material of standard clinical textbooks verbatim and could recite
that material in the care of patients … mastered, but also had an ability to analyze and apply
original research articles in the care of the patients … was the first person I encountered who masterfully demonstrated the application of
these methods to patient
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
June 24, 2022 - NEST_data • Patient-centeredness: Patients are engaged in the RWD/RWE process and provide consent when … NAM 2018 Safety monitoring in real-world trials
NAM 2018 Results more generalizable and relevant
NAM … NAM2019 Questions to consider regarding participant safety and investigator control of treatments in … NAM2019 How much would the effectiveness or safety of the study treatment(s) vary among providers or … NAM2019 Is there some minimal or floor level of treatment quality necessary to assure participant safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hospital-length-of-stay-disposition-comments_0.pdf
September 20, 2021 - In addition,
ICU LOS is often seen as an important measure (from a quality of
care and safety standpoint … coaching), healthcare delivery
processes, managed care and risk
management, and hospital quality and
safety … Ideally there
would be more patient or family stakeholder KIs. … coaching), healthcare delivery
processes, managed care and risk
management, and hospital quality and
safety … Presumably the patient level factors that drive
prolonged length of hospital stay in patients with multi
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
June 01, 2022 - How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical or … How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical comorbidities … How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical and … safety and pain management: a
systematic review and meta-analysis. … Effect
of intensive patient education vs placebo
patient education on outcomes in patients
with acute
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
November 01, 2020 - A 1-year safety and efficacy study of duloxetine in
patients with fibromyalgia. … Evaluation of efficacy and safety of gabapentin,
duloxetine, and pregabalin in patients with painful … Comparative safety and tolerability of duloxetine vs. … in patients with moderate-to-severe chronic
low back pain. … Safety and efficacy of tapentadol ER in patients
with painful diabetic peripheral neuropathy: results
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - Further characterization
of the comparative safety of antidepressants is
difficult because few studies … Comparative efficacy
and safety of sertraline versus nortriptyline in major
depression in patients … Safety and
tolerability of duloxetine at 60 mg once daily in
elderly patients with major depressive … double-
blind, placebo-controlled, duloxetine-referenced,
fixed-dose study comparing the efficacy and safety … Are old-old
patients with major depression more likely to relapse
than young-old patients during continuation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement-may-2025.pdf
January 01, 2025 - regulation and management, behavioral planning, family engagement
and communication training, and practical safety … intervals), directness of the evidence to the
KQs (focusing on whether the outcomes were important to patients … Intervention research with persons at high risk for
suicidality: safety and ethical considerations. … The SAFETY program: a treatment-development
trial of a cognitive-behavioral family treatment for adolescent … Key Informants
Key Informants are the end-users of research; they can include patients and caregivers
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
November 06, 2013 - Key Questions
from Nominator:
Patient … factors prompting
the admission
Individual and family felt the stay was sufficient to address safety … hospitalizations for persons with SMI
and the circumstances surrounding hospitalization that promote positive patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Patient
safety in ambulatory settings. … VA National Center for
Patient Safety . … Veterans Affairs (VA)
managers and policymakers
VA National Center for
Patient Safety
"improve … with
STEMI
Few trials followed patients
long-term and lack of data
regarding safety
C-10 … Patient
safety in ambulatory settings.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a
class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials
treated with epoetin alfa … analyzed individual patient data from 2,122 patients in 6 trials receiving darbepoetin
alpha finding … Study and Independent Patient Level Meta-Analysis Selection:
Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for
patients with cancer--meta-analysis based on individual patient data
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
December 09, 2009 - when the patient is treatment resistant. … For adults with treatment-resistant depression, do non-pharmacologic interventions differ in
safety, … Comparators: ECT, rTMS, VNS, demonstrated effective psychotherapy
• Outcomes for each question
• Safety … KQ4 focuses on safety issues (adverse effects, adherence) with
each of the interventions. … While the patient is ultimately the one to make the decision about whether to receive the non-
pharmacologic